Date: 2016-10-26
Type of information: Nomination
Compound:
Company: Allergan (Ireland)
Therapeutic area:
Type agreement: nomination
Action mechanism:
Disease:
Details: * On October 26, 2016, Allergan announced changes to leadership roles within its board of directors. Effective immediately, Brenton L. Saunders has been elected Chairman of the Allergan's Board of Directors replacing Paul Bisaro , who served as Executive Chairman since July 1 , 2014. Paul Bisaro will remain a member of the Allergan Board of Directors. In addition to the role of Chairman, Saunders will retain his current role as Chief Executive Officer and President. Also, effective today, Christopher Coughlin has been elected Lead Independent Director. "In 2013, Actavis was a leading global generics company when we began our transformation into a branded leader by acquiring Warner Chilcott . We followed that by acquiring Forest Laboratories in 2014 and Allergan in 2015," said Paul Bisaro . "With the sale of our Global Generics business to Teva in August 2016 and our Anda distribution business in October 2016 , we have now completed the transformation to a global branded Growth Pharma company with operations in nearly 100 countries and annual sales of approximately $15 billion . With this transformation complete, this is the right time to transition leadership of the Allergan Board of Directors to Brent, who has led the company so ably since becoming CEO and President in July 2014." Saunders has served as a member of Allergan's Board of Directors and as Chief Executive Officer and President since July 2014 . He was previously Chief Executive Officer and President of Forest and a member of the Board of Directors of Forest. He is currently a member of the Board of Trustees of the University of Pittsburgh , The Business Council and PhRMA.
Paul Bisaro served as Executive Chairman of Allergan's Board of Directors since July 2014 . He previously served as our President and Chief Executive Officer and as Chairman of our Board of Directors beginning October 2013 ; prior to serving as Chairman he served on the Board of Directors beginning September 2007 . He currently serves on the Boards of Directors of Zimmer Biomet Holdings, Inc. and Zoetis, Inc. and on the Board of Visitors of the Catholic University of America's Columbus School of Law .
Financial terms:
Latest news:
